WHO ICTRP trial
Outpatient Ifosfamide, Etoposide plus Rituximab (R-IE) for salvage in patients >…
ACTRN12606000373572 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12606000373572 |
|---|---|
| Public title | Outpatient Ifosfamide, Etoposide plus Rituximab (R-IE) for salvage in patients > 60 years with relapsed or refractory CD20 positive diffuse large B-cell lymphoma who are not candidates for stem cell transplant study |
| Scientific title | A phase IV study to evaluate the treatment response (Complete Response [CR]and Partial Response [PR] of out-patient Ifosfamide, Etoposide plus Rituximab (R-IE) for salvage in patients >60 years with relapsed or refractory CD20 positive diffuse large B-cell lymphoma who are not candidates for stem… |
| Primary sponsor | Roche |
| Secondary sponsors | Amgen & Baxter |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 3 / Phase 4 |
| Countries | Australia |
| Conditions | Relapsed or refractory CD20 positive diffuse large B-cell lymphoma; Relapsed or refractory CD20 positive diffuse large B-cell lymphoma;Cancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma |
| Interventions | Rituximab 375 mg/m2 iv on day 1 Ifosfamide 5,000 mg/m2 iv in equally divided doses over 3 days (days 1-3) Etoposide 100 mg/m2 iv daily for days 1 to 3 Pegfilgrastim 6 mg subcutaneous (SC) on day 4 6 cycles (21 days in each cycle) |
| Registration date | Aug 25, 2006 |
| Target size | 40 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: